DWA
GLSI icon

Dorsey Wright & Associates’s Greenwich LifeSciences GLSI Stock Holding History

Dorsey Wright & Associates’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,118
Closed -$44K – 295
2021
Q3 		$44K Buy
+1,118
New +$46.7K 0.01% 239

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dorsey Wright & Associates's GLSI Position: Q4 2021 in Review

Dorsey Wright & Associates sold out of Greenwich LifeSciences (GLSI) in Q4 2021, closing a stake of 1,118 shares — an estimated $44K sold.

Dorsey Wright & Associates first reported a position in GLSI in Q3 2021 and held it in 1 quarter. The position peaked at $44K in Q3 2021. 35 funds tracked by Wall St. Rank hold GLSI as of Q4 2021.

  • Dorsey Wright & Associates reported no remaining Greenwich LifeSciences position as of Q4 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,118 Greenwich LifeSciences shares in Q4 2021, an estimated $44K.
  • Dorsey Wright & Associates first reported a position in Greenwich LifeSciences in Q3 2021 and held it in 1 quarter.
  • Dorsey Wright & Associates's Greenwich LifeSciences position peaked at $44K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2021.

Based on Dorsey Wright & Associates's 13F filing for Q4 2021, filed 27 Jan 2022.